The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame

15 hours ago

What to know about testosterone replacement as U.S. military plans to test troops

15 hours ago

Market case for psychedelic drugs to treat mental health gets a big buy signal

18 hours ago

Fat cat? Weight-loss drugs may be coming for your overweight pet

3 days ago

Trump rips Canada for wildfire smoke, threatens to raise tariffs

3 days ago

Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants

3 days ago

World's largest olive oil company says market has 'definitively' entered new phase

4 days ago

Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape

4 days ago

3 of our stocks rode the AI rally, while 3 others fell out of favor since last month

4 days ago

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion

4 days ago

UnitedHealth beats quarterly estimates, hikes profit outlook

4 days ago

J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

5 days ago

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

6 days ago

A tiny GLP-1 implant is the latest bet to help patients maintain weight loss

6 days ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?

9 days ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer

10 days ago

AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse

11 days ago

Employers aren't expanding coverage of GLP-1 obesity drugs, survey says

12 days ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

14 days ago

Ebola outbreak harder to contain after USAID, Western aid cuts, experts say

14 days ago

Jim Cramer says this former Covid market darling is finally investable again

19 days ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

19 days ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

20 days ago

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

20 days ago

Medicare will start covering obesity drugs. Here's what patients should know

20 days ago

French biotech stock soars 40% after new data on experimental medicine

20 days ago

FDA names first companies chosen for faster review of new manufacturing plants

21 days ago

Medicare is about to cover obesity drugs — but many seniors may not know it yet

22 days ago

Estrogen patches are hard to find, and it may not be resolved any time soon

24 days ago

Chan Zuckerberg Initiative's Biohub to open new rare disease funding round

25 days ago

This life sciences stock has a secret weapon, and AI will only make it more valuable

26 days ago

Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy

26 days ago